mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.

Document Type

Article

Publication Date

4-2022

Identifier

DOI: 10.1016/j.jpeds.2021.12.025; PMCID: PMC8691954

Abstract

In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.

Journal Title

The Journal of pediatrics

Volume

243

First Page

208

Last Page

213

MeSH Keywords

Adolescent; COVID-19; COVID-19 Vaccines; Humans; Myocarditis; RNA, Messenger

Keywords

mRNA COVID-19 vaccine-associated myopericarditis; outcomes; survey; variability

Link to Full Text
Library Record

Share

COinS